An Approach to Nonsuppressed Testosterone in Transgender Women Receiving Gender-Affirming Feminizing Hormonal Therapy

被引：10

作者：

Maheshwari, Arvind ^{[1
]}

Nippoldt, Todd ^{[1
]}

Davidge-Pitts, Caroline ^{[1
]}

机构：

[1] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, 200 First St SW, Rochester, MN 55905 USA

来源：

JOURNAL OF THE ENDOCRINE SOCIETY | 2021年 / 5卷 / 09期

关键词：

transgender; hormones; testosterone; estrogen; anti-androgen; TRANSWOMEN; ESTROGENS;

D O I：

10.1210/jendso/bvab068

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Nonsuppressed levels of testosterone are seen in up to a quarter of transgender women on gender-affirming feminizing hormonal treatment. Multiple factors contribute to this situation, including patient, medication, laboratory, and organ-specific concerns. We propose a stepwise approach to determine the etiology of nonsuppressed levels of testosterone in transgender women. This may lead to an appropriate feminizing hormonal therapy regimen and diagnosis of manageable medical conditions.

引用

页数：7

共 27 条

[1] Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy
Angus, Lachlan
Leemaqz, Shalem
Ooi, Olivia
Cundill, Pauline
Silberstein, Nicholas
Locke, Peter
Zajac, Jeffrey D.
Cheung, Ada S.
[J]. ENDOCRINE CONNECTIONS, 2019, 8 (07): : 935 - 940
[2] Low Free Testosterone Is Associated with Hypogonadal Signs and Symptoms in Men with Normal Total Testosterone
Antonio, Leen
Wu, Frederick C. W.
O'Neill, Terence W.
Pye, Stephen R.
Ahern, Tomas B.
Laurent, Michael R.
Huhtaniemi, Ilpo T.
Lean, Michael E. J.
Keevil, Brian G.
Rastrelli, Giulia
Forti, Gianni
Bartfai, Gyorgy
Casanueva, Felipe F.
Kula, Krzysztof
Punab, Margus
Giwercman, Aleksander
Claessens, Frank
Decallonne, Brigitte
Vanderschueren, Dirk
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (07) : 2647 - 2657
[3] Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review
Asscheman, H.
T'Sjoen, G.
Lemaire, A.
Mas, M.
Meriggiola, M. C.
Mueller, A.
Kuhn, A.
Dhejne, C.
Morel-Journel, N.
Gooren, L. J.
[J]. ANDROLOGIA, 2014, 46 (07) : 791 - 795
[4] Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline
Bhasin, Shalender
Brito, Juan P.
Cunningham, Glenn R.
Hayes, Frances J.
Hodis, Howard N.
Matsumoto, Alvin M.
Snyder, Peter J.
Swerdloff, Ronald S.
Wu, Frederick C.
Yialamas, Maria A.
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (05) : 1715 - 1744
[5] Centers for Disease Control and Prevention, HOST VDSCP HORM VIT
[6] Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study
de Blok, Christel Josefa Maria
Klaver, Maartje
Wiepjes, Chantal Maria
Nota, Nienke Marije
Heijboer, Annemieke Corine
Fisher, Alessandra Daphne
Schreiner, Thomas
T'Sjoen, Guy
den Heijer, Martin
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (02) : 532 - 538
[7] Effects of Cross-Sex Hormone Treatment on Transgender Women and Men
Deutsch, Madeline B.
Bhakri, Vipra
Kubicek, Katrina
[J]. OBSTETRICS AND GYNECOLOGY, 2015, 125 (03) : 605 - 610
[8] Doll EE, 2020, J ENDO SOC S1, V4, DOI [10.1210/jendso/bvaa046.2237, DOI 10.1210/JENDSO/BVAA046.2237]
[9] Unmasked Testicular Seminoma During Use of Hormonal Transgender Woman Therapy: A Hidden hCG-Secreting Tumor
Elshimy, Ghada
Tran, Kelvin
Harman, Sherman M.
Correa, Ricardo
[J]. JOURNAL OF THE ENDOCRINE SOCIETY, 2020, 4 (07)
[10] Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness
Gava, Giulia
Cerpolini, Silvia
Martelli, Valentina
Battista, Giuseppe
Seracchioli, Renato
Meriggiola, Maria Cristina
[J]. CLINICAL ENDOCRINOLOGY, 2016, 85 (02) : 239 - 246

← 1 2 3 →